ArticleFrontiers in medicine2025
Evaluation of sarcopenia in female patients with fibromyalgia syndrome: an ultrasonographic approach.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this study is to evaluate sarcopenia in female patients with Fibromyalgia Syndrome (FMS), according to diagnostic algorithms, in terms of total and regional muscle mass measurements. Methods: The study included 60 female patients diagnosed with FMS (mean [M] = 47.78 years, Standard deviation [SD] = 4.72 years) and 30 healthy women (M = 49.8 years, SD = 4.8 years). The ages and anthropometric measurements were noted, and participants evaluated using the Widespread Pain Index, Symptom Severity Scale, Visual Analog Scale, Fatigue Severity Scale, Beck Depression Inventory, International Physical Activity Questionnaire, and the Fibromyalgia Impact Questionnaire. Results: The hand grip strength and gait speed values of the patient group were found to be lower than those of the control group, and the chair stand test value higher than that of the control group. There was a statistically significant difference between the groups ( Conclusion: The female patients with FMS were dynapenic, which means a loss of muscle function without a loss of muscle mass.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.